Latest News of AMRX
Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%
By Yahoo! Finance |
2 weeks ago
Amneal Pharmaceuticals stock has shown impressive growth of 211% in five years, with a recent 19% rise. Despite profit fluctuations, its revenue has grown steadily. Shareholders are optimistic about f...
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
Amneal and Metsera have formed a strategic collaboration to create and distribute a range of advanced medications for obesity and metabolic diseases worldwide. The partnership aims to expedite the dev...
Insider Sale at Amneal Pharmaceuticals Inc (AMRX) by Executive Vice President Andrew Boyer
By Yahoo! Finance |
3 months ago
Andrew Boyer, Executive VP of Amneal Pharmaceuticals Inc, sold 62,711 shares, now owning 256,670 shares. The company has seen insider selling recently, with no buys. With a market cap of $2....
-
Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President Nikita Shah Sells ...
By Yahoo! Finance | 3 months agoAmneal Pharmaceuticals Inc has witnessed insider selling activity, with shares priced at $7.75. The company's market cap is $2.49 billion, but the stock is deemed significantly overvalued with an intr...
-
In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
By Yahoo! Finance | 3 months agoAmneal Pharmaceuticals (NASDAQ:AMRX) has 5 investors owning a majority stake of 51%. Insiders hold 53% shares, indicating control. Institutional ownership and analyst sentiments impact stock performan...